Skip to main content
. 2020 Sep 17;5(18):e140066. doi: 10.1172/jci.insight.140066

Figure 4. ERK1/2 inhibition caused alteration of DSG2 localization.

Figure 4

Immunostainings of HL-1 cells treated with F/R, PMA, or SB20, with and without U0126, stained for N-CAD and DSG2 under basal conditions. DMSO serves as control for SB20 treatment. Arrows indicate increased localization of DSG2 in the membrane. Scale bar: 10 μm. n = 6.